BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 25057165)

  • 1. The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck.
    Psyrri A; Rampias T; Vermorken JB
    Ann Oncol; 2014 Nov; 25(11):2101-2115. PubMed ID: 25057165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16, HPV, and Cetuximab: What Is the Evidence?
    Bonner JA; Mesia R; Giralt J; Psyrri A; Keilholz U; Rosenthal DI; Beier F; Schulten J; Vermorken JB
    Oncologist; 2017 Jul; 22(7):811-822. PubMed ID: 28526718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial.
    Vermorken JB; Psyrri A; Mesía R; Peyrade F; Beier F; de Blas B; Celik I; Licitra L
    Ann Oncol; 2014 Apr; 25(4):801-807. PubMed ID: 24577117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of outcomes of locoregionally advanced oropharyngeal and non-oropharyngeal squamous cell carcinoma over two decades.
    Das LC; Karrison TG; Witt ME; Muller C; Stenson K; Blair EA; Cohen EEW; Seiwert TY; Haraf DJ; Vokes EE
    Ann Oncol; 2015 Jan; 26(1):198-205. PubMed ID: 25361984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controversies and role of HPV16 in recurrent/metastatic squamous cell cancers of the head and neck.
    Misiukiewicz K; Bonomi M; Demicco E; Posner M
    Ann Oncol; 2014 Aug; 25(8):1667-8. PubMed ID: 24875798
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
    Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Papillomavirus (HPV): A Criterion for Therapeutic Decision in Squamous Cell Carcinoma of the Head and Neck?
    Vermorken JB
    Recent Results Cancer Res; 2017; 206():137-147. PubMed ID: 27699535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
    Vermorken JB; Stöhlmacher-Williams J; Davidenko I; Licitra L; Winquist E; Villanueva C; Foa P; Rottey S; Skladowski K; Tahara M; Pai VR; Faivre S; Blajman CR; Forastiere AA; Stein BN; Oliner KS; Pan Z; Bach BA;
    Lancet Oncol; 2013 Jul; 14(8):697-710. PubMed ID: 23746666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
    Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.
    Guo T; Qualliotine JR; Ha PK; Califano JA; Kim Y; Saunders JR; Blanco RG; D'Souza G; Zhang Z; Chung CH; Kiess A; Gourin CG; Koch W; Richmon JD; Agrawal N; Eisele DW; Fakhry C
    Cancer; 2015 Jun; 121(12):1977-84. PubMed ID: 25782027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma.
    Fung N; Faraji F; Kang H; Fakhry C
    Cancer Metastasis Rev; 2017 Sep; 36(3):449-461. PubMed ID: 28812214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
    Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
    Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De-Escalating Strategies in HPV-Associated Head and Neck Squamous Cell Carcinoma.
    Economopoulou P; Kotsantis I; Psyrri A
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of HPV status in recurrent/metastatic squamous cell carcinoma of the head and neck.
    Misiukiewicz K; Camille N; Gupta V; Bakst R; Teng M; Miles B; Genden E; Sikora A; Posner M
    Clin Adv Hematol Oncol; 2014 Dec; 12(12):812-9. PubMed ID: 25674839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma.
    Dalianis T
    Presse Med; 2014 Dec; 43(12 Pt 2):e429-34. PubMed ID: 25455638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term prognosis and risk factors among patients with HPV-associated oropharyngeal squamous cell carcinoma.
    Lin BM; Wang H; D'Souza G; Zhang Z; Fakhry C; Joseph AW; Drake VE; Sanguineti G; Westra WH; Pai SI
    Cancer; 2013 Oct; 119(19):3462-71. PubMed ID: 23861037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staging and treatment of oropharyngeal cancer in the human papillomavirus era.
    Ward MJ; Mellows T; Harris S; Webb A; Patel NN; Cox HJ; Piper K; Ottensmeier CH; Thomas GJ; King EV
    Head Neck; 2015 Jul; 37(7):1002-13. PubMed ID: 24753272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.